PEPTIDES for Veterans Act
Sponsored By: Representative Mace, Nancy [R-SC-1]
Introduced
Summary
This bill would create a staged VA process to define, study, and potentially pilot the use of peptide-based therapies for veterans. It prioritizes a clear definition first, then an evidence review and an optional voluntary pilot if safety and benefit are shown.
Show full summary
- Veterans: Would set up a path to study and possibly access peptide-based treatments for recovery, chronic pain, mental health, rehabilitation, and other service-connected conditions. Participation in any pilot would be voluntary.
- VA clinicians and facilities: Would get a required review of current rules and a mandate to develop clinical protocols and safety assessments as part of an 18-month study and a later pilot program.
- Oversight and reporting: The Secretary must report to Congress within 180 days with definitions and within 18 months with study findings and recommendations, and must run a pilot up to 5 years if the study supports it.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Peptide therapy study and pilot for veterans
This bill would require the VA to study peptide-based therapies for veterans who get care at VA medical facilities. The study would start when the VA submits its peptide-definition report to Congress and must finish within 18 months. The VA would report findings, recommendations, and whether to offer therapies at VA facilities. If the VA recommends offering them, the bill would require a voluntary pilot for veterans who choose to join. The pilot must finish within five years of starting. The VA could limit the pilot by location or medical rules and would report on effectiveness and steps to expand care.
Sponsors & CoSponsors
Sponsor
Mace, Nancy [R-SC-1]
SC • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov